Biodiem share price
WebBDM BIODIEM FPO Basic Materials. Diamonds Gold Silver. $0.300 (0%) High-Low-Trades-Turnover. $0: Volume. 0: 13 April 2024 at 8:20pm Track Stock ... Price Sensitive News … WebApr 26, 2012 · BioDiem contact info: Phone number: +61 396927222 Website: www.biodiem.com What does BioDiem do? BioDiem (ASX: BDM) is an ASX-listed company based in Melbourne with an international focus on discovering, developing and commercialising world-class research and technology targeting infectious diseases and …
Biodiem share price
Did you know?
WebBioDiem Ltd. (ASX:BDM), Melbourne, Australia Business: Infectious, Ophthalmic Date completed: 6/25/10 Type: Rights offering Raised: A$3.5 million (US$3.1 million) Shares: 19.5 million Price: A$0.18 Shares after offering: 94.4 million Investors: Existing investors Note: Shareholders were... WebJul 12, 2010 · Published: Jul 12, 2010. Melbourne, Monday 12 July 2010: (ASX: BDM) BioDiem Ltd’s lead product, the Live Attenuated Influenza Vaccine (LAIV) has been granted regulatory approval for marketing in India. “NasoVac” was launched this week by the Indian vaccine company, the Serum Institute of India (“SII”). This is the first approval for ...
WebBioDiem Summary. Company summary. Overview. BioDiem is a biopharmaceutical company focused on developing and commercializing vaccines and infectious disease therapies. It offers LAIV (Live Attenuated Influenza Virus) vaccine technology that is used for the production of seasonal and pandemic influenza vaccines and is given intranasally. WebMar 29, 2024 · Griffith University’s Industry Fund collaborates in BDM-I screening. April. 30/04/2014. Completion of Non-renounceable Entitlement Offer and Issue of Entitlement and Shortfall Shares. BDM-I antimicrobial – mechanism of action investigation. 23/04/2014. Non-Renounceable Entitlement Offer – Closure, Acceptances and Shortfall. 10/04/2014.
http://www.biodiem.com/announcements/ WebThe trial investigated the tolerability and immunogenicity of escalating single doses of SCH 900795 [LAIV; BioDiem], an intranasal, live attenuated influenza A phase 1 trial of escalating doses of LAIV (SCH 900795) seasonal vaccine in healthy adults. ... Price : $35 * Buy Profile. Adis is an information provider. ...
WebNov 23, 2024 · Key Companies in Influenza Vaccine Market are GlaxoSmithKline plc, Sanofi S.A, AstraZeneca, Seqirus, BioDiem, Emergent Bio Solutions Inc, Sinovac Biotech Ltd, Other Prominent PlayersPune, India ...
WebBIODIEM LTD. : News, information and stories for BIODIEM LTD. Australian Stock Exchange: Australian Stock Exchange orc for having weapons under disabilityWebLegal Name BioDiem Ltd. Company Type For Profit. Contact Email [email protected]. Phone Number + 61 3 9692 7240. BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Their business model is to generate income from partnerships including with … orc football helmet iconWebJan 4, 2024 · Download Share Price History for Biodiem Ltd [ASX,BDM] in a range of formats. ASX, BDM End of Day and Historical Share Prices [Biodiem Ltd] The worlds #1 website for end of day & historical stock data orc for ipv snapWebFind the latest ALBIREO PHARMA INC (BIOD) stock quote, history, news and other vital information to help you with your stock trading and investing. iprint whetstonehttp://www.biodiem.com/ orc for headlightsWebAug 7, 2012 · Published: Aug 07, 2012. Melbourne, 8 August 2012: Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, … iprint und scan windows 10WebBiodiem Def share price and BDMN stock charts. Free real-time prices and the UK's most active stock market forums. Biodiem Def (BDMN) share price, charts, trades & the UK's … orc for inducing panic